Table 1.
Demographic and clinical characteristics in patients with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and healthy controls.
| Healthy controls (n = 16) | Patients with PSP (n = 20) | Patients with CBS (n = 11) | p Value* | p Value** | p Value*** | |
|---|---|---|---|---|---|---|
| Age (years) | 69.38 ± 4.9 | 69.28 ± 4.8 | 66 ± 3.9 | 0.95 | 0.06 | 0.06 |
| Male/female | 7/9 | 10/10 | 3/8 | 0.97 | 0.38 | 0.21 |
| Disease duration (years) | – | 3.17 ± 1.75 | 2.72 ± 1.27 | – | – | 0.46 |
| UPDRS-III | – | 27.2 ± 16.4 | 33.9 ± 24.5 | – | – | 0.36 |
| H&Y | – | 3.05 ± 1.02 | 2.3 ± 1.7 | – | – | 0.13 |
| MMSE | 29.4 ± 0.9 | 24.06 ± 3.78 | 27.45 ± 2 | 0.004 | 0.002 | 0.01 |
| FAB | – | 11.05 ± 3.64 | 15.7 ± 1.55 | – | – | 0.0004 |
UPDRS-III, Unified Parkinson’s Disease Rating Scale; H&Y, Hoehn and Yahr scale; MMSE, Mini-Mental State Examination; FAB, Frontal Assessment Battery.
Values are reported as mean ± SD.
*Differences between healthy controls and PSP (unpaired t-test).
**Differences between healthy controls and CBS (unpaired t-test).
***Differences between PSP and CBS (unpaired t-test).
Sex differences were assessed by χ2 test.
Significant p values are indicated in bold.